<DOC>
	<DOCNO>NCT01980667</DOCNO>
	<brief_summary>Clinical Pharmacokinetic Study Lurbinectedin ( PM01183 ) Combination Cisplatin Patients Advanced Solid Tumors determine recommend dose ( RD ) PM01183 combination cisplatin , characterize safety profile , pharmacokinetics ( PK ) combination , obtain preliminary information clinical antitumor activity conduct exploratory pharmacogenomic ( PGx ) analysis .</brief_summary>
	<brief_title>Study Lurbinectedin ( PM01183 ) Combination With Cisplatin Patients With Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Voluntarily sign write informed consent Age ≥ 18 year old Eastern Cooperative Oncology Group ( ECOG ) performance status ( PS ) ≤ 1 . Life expectancy ≥ 3 month . Patients confirm diagnosis advance solid tumor . Patients may receive ≤ 2 chemotherapycontaining line advance set . Adequate bone marrow , renal , hepatic , metabolic function ( assessed ≤ seven day inclusion study ) Recovery stabilization grade ≤ 1 adverse event derive previous treatment ( grade 2 alopecia asthenia/fatigue allow ) . No clinically significant change ECG . At least four week since last monoclonal antibody contain therapy definitive radiotherapy ( RT ) At least two week since last biological/investigational singleagent therapy ( exclude MAbs ) and/or palliative RT ( ≤10 fraction ≤30 Gy total dose ) Fertil woman must pregnancy excluded appropriate testing study entry Prior treatment PM01183 trabectedin . Concomitant diseases/conditions : History within last year presence unstable angina , myocardial infarction , congestive heart failure , clinically relevant valvular heart disease symptomatic arrhythmia asymptomatic ventricular arrhythmia require ongoing treatment . Ongoing , nonneoplastic , chronically active liver disease origin . Active infection . Patients require ongoing oxygen support . Known human immunodeficiency virus ( HIV ) infection . Any major illness . Symptomatic corticosteroidrequiring brain metastasis leptomeningeal disease involvement . Patients asymptomatic document stable brain metastasis require corticosteroid last three month allow . Peripheral sensory/motor neuropathy grade &gt; 1 . Hearing impairment grade &gt; 1 . Fertile men woman use effective method contraception . History bone marrow stem cell transplantation Radiotherapye &gt; 35 % bone marrow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>lurbinectedin</keyword>
	<keyword>PM01183</keyword>
	<keyword>tumor</keyword>
	<keyword>cancer</keyword>
	<keyword>Pharma Mar</keyword>
</DOC>